drugset / Trial / NCT01229098

Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris

NCT01229098

Phase 2 Completed 102 enrolled LEO Pharma
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of once daily use of LEO 80185 gel on the hypothalamic-pituitary-adrenal (HPA) axis and calcium metabolism in subjects with extensive psoriasis vulgaris.

Timeline

Start
2010-10
Primary completion
2011-09
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule 50 ug Topical
Subject betamethasone dipropionate Small molecule 0.5 mg Topical

Indications